Water Potentiates the Pressor Effect of Ephedra Alkaloids

Department of Medicine and Pharmacology, Vanderbilt University, Nashville, Tenn 37212, USA.
Circulation (Impact Factor: 14.43). 05/2004; 109(15):1823-5. DOI: 10.1161/01.CIR.0000126283.99195.37
Source: PubMed


The use of ephedra alkaloids in over-the-counter preparations has been associated with potentially serious cerebrovascular events. Because of its potential association with hemorrhagic strokes, phenylpropanolamine has been largely substituted for by pseudoephedrine, but it is not clear whether this is indeed a safer alternative. It would be important to understand the cardiovascular effects of ephedra alkaloids, but these are normally masked by baroreflex buffering mechanisms. We therefore investigated the effects of ephedra alkaloids in patients with autonomic impairment and explored their potential interaction with water ingestion.
The cardiovascular effects of phenylpropanolamine or pseudoephedrine, alone and in combination with water, were determined in 13 subjects with impairment of baroreflex function due to autonomic failure. Phenylpropanolamine, 12.5 to 25 mg PO, increased systolic blood pressure (SBP) by 21+/-14 mm Hg after 90 minutes. However, when ingested with 16 oz of room temperature tap water, phenylpropanolamine increased SBP by 82+/-2 mm Hg. Pseudoephedrine, 30 mg PO, increased SBP on average 52+/-9 mm Hg when taken with 16 oz of water and by as much as 88 mm Hg.
Ephedra alkaloids increase blood pressure significantly in individuals with impaired baroreflex function. Concomitant ingestion of ephedra alkaloids and water produced a greater increase in blood pressure. If used cautiously, this interaction can be beneficial in the treatment of orthostatic hypotension. On the other hand, it could contribute to the cardiovascular complications associated with the use of ephedra alkaloids, given that baroreflex function varies widely in normal individuals and is impaired in several medical conditions.

Download full-text


Available from: André Diedrich, Jul 12, 2014
9 Reads
  • Source
    • "The spreading of total daily carbohydrate intake to multiple smaller meals was shown to beneficially affect orthostatic symptoms [39]. The effect of 500 ml oral water ingestion typically increases blood pressure 20–30 mmHg for about an hour, and sometimes greatly potentiates the pressor effect of other drugs [28]. Finally, adequate salt and fluid intake may be useful with dietary sodium intake of at least 10 g per day and a fluid intake of more than 2 l per day [14, 29, 68, 78]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neurogenic orthostatic hypotension is a distinctive and treatable sign of cardiovascular autonomic dysfunction. It is caused by failure of noradrenergic neurotransmission that is associated with a range of primary or secondary autonomic disorders, including pure autonomic failure, Parkinson's disease with autonomic failure, multiple system atrophy as well as diabetic and nondiabetic autonomic neuropathies. Neurogenic orthostatic hypotension is commonly accompanied by autonomic dysregulation involving other organ systems such as the bowel and the bladder. In the present review, we provide an overview of the clinical presentation, pathophysiology, epidemiology, evaluation and management of neurogenic orthostatic hypotension focusing on neurodegenerative disorders.
    Journal of Neurology 11/2012; 260(9). DOI:10.1007/s00415-012-6736-7 · 3.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent studies suggest that water drinking elicits acute changes in human physiology. Water drinking profoundly increases blood pressure in patients with autonomic failure. Water drinking also increases blood pressure in quadriplegic patients, cardiac transplant recipients, and older healthy subjects, but to a lesser extent. Blood pressure does not change in healthy young subjects. More recently, water drinking was shown to increase energy expenditure. The acute changes in cardiovascular regulation and in energy expenditure with water drinking appear to be mediated through activation of the sympathetic nervous system. The sympathetic activation may involve a spinal reflex-like mechanism. The stimulus that causes the sympathetic activation is not known. The acute water pressor response can be exploited in the treatment of patients with impaired orthostatic tolerance caused by autonomic failure, postural tachycardia syndrome, or, perhaps, neurocardiogenic (vasovagal) syncope. The increase in energy expenditure with water drinking should be recognized as an important confounding variable in metabolic studies and may hold some promise as an adjunctive measure in the prevention or treatment of obesity.
    Current Hypertension Reports 03/2005; 7(1):17-20. DOI:10.1007/s11906-005-0050-z · 3.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This chapter discusses several drugs that affect autonomic functions or the extrapyramidal system. Adrenaline is widely used in topical anesthesia, when of course systemic administration is not intended. Adrenaline is also used as an adjunct to interscalene block during shoulder surgery, which is often performed with the patient in a sitting position. The use of ephedrine alone or ephedrine plus caffeine is associated with an increased risk of psychiatric, autonomic, gastrointestinal, and cardiovascular symptoms. The hazard associated with use of over-the-counter nutritional supplements by athletes has been observed in several cases. Piribedil is a dopamine receptor agonist that has been used for past several years in the treatment of Parkinson's disease but has received comparatively little attention. However, its pharmacology is unusual, in that it is an agonist at D3 as well as D" receptors. Very few cases of sleep attacks have been described in association with piribedil. Complex behavioral changes can apparently be caused by medication in Parkinson's disease. High-dose dopamine receptor agonist therapy has been associated with excessive gambling, which can be regarded as pathological.
    Side Effects of Drugs Annual 12/2005; 28(1):160-167. DOI:10.1016/S0378-6080(05)80435-0
Show more